Denosumab in Postmenopausal Women with Low Bone Mineral Density
2006 · New England Journal of Medicine · 1,207 citations
https://doi.org/10.1056/nejmoa044459
P
Paul D. Miller
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
351
Papers
25.7K
Citations
80
h-index
208
i10-index
Paul D. Miller is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Bone health and treatments & Bone health and osteoporosis research & Parathyroid Disorders and Treatments. The author has an h-index of 80, co-authored 299 publications.
ORCID: 0000-0002-5347-7457Papers by this author
worksObservations following discontinuation of long-term denosumab therapy
2017 · Osteoporosis International · 216 citations
https://doi.org/10.1007/s00198-017-3919-1
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
2012 · Osteoporosis International · 113 citations
https://doi.org/10.1007/s00198-012-2052-4
Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
2010 · Calcified Tissue International · 107 citations
https://doi.org/10.1007/s00223-010-9424-6
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
2015 · Osteoporosis International · 76 citations
https://doi.org/10.1007/s00198-015-3179-x
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group
2019 · Osteoporosis International · 25 citations
https://doi.org/10.1007/s00198-019-05020-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat